Circulating levels of miR-24 are shown in patients with slight neurological impairment (group 1) compared to patients with moderate and severe impairment (group 2 and 3).

<p>Circulating levels of miR-24 are shown in patients with slight neurological impairment (group 1) compared to patients with moderate and severe impairment (group 2 and 3).</p

Demographic, clinical and laboratory characteristics of patients.

<p>eGFR = estimated glomerular filtration rate; Hb = hemoglobin count; ICU = intensive care unit; LDH = Lactic acid dehydrogenase; PE = plasma exchange; Values of circulating miRNAs represent a ratio between the expression of miRNAs of interest normalized to spiked-in C.elegans control miRNAs.</p

Circulating levels of miR-24 and miR-126 in patients with EHEC-HUS (HUS, n = 38) compared to healthy controls (CTL, n = 21) at baseline (A, B) and during follow-up (n = 29; C, D) are shown.

<p>Data are displayed as mean ± standard deviation (SD).</p

sj-docx-1-tan-10.1177_17562864221122491 – Supplemental material for Advancement of door-to-needle times in acute stroke treatment after repetitive process analysis: never give up!

Supplemental material, sj-docx-1-tan-10.1177_17562864221122491 for Advancement of door-to-needle times in acute stroke treatment after repetitive process analysis: never give up! by Johanna Ernst, Kai F. Storch, Anh Thu Tran, Maria M. Gabriel, Andrei Leotescu, Anna-Lena Boeck, Meret K. Huber, Omar Abu-Fares, Paul Bronzlik, Friedrich Götz, Hans Worthmann, Ramona Schuppner, Gerrit M. Grosse and Karin Weissenborn in Therapeutic Advances in Neurological Disorders</p

Genome-wide qRT-PCR-based screen of deregulated miRNAs in HUS patients in comparison to healthy controls.

<p>Genome-wide qRT-PCR-based screen of deregulated miRNAs in HUS patients in comparison to healthy controls.</p

Correlation between miR-126 and platelet count on admission (A) and day 35 (B) as well as correlation between miR-24 and platelet count on day 42 (C) and day 49 (D) is shown.

<p>Correlation between miR-126 and platelet count on admission (A) and day 35 (B) as well as correlation between miR-24 and platelet count on day 42 (C) and day 49 (D) is shown.</p